Dog /

Breed profile · FDA CVM July 2026 extract

Newfoundland adverse-event record

Adverse-event filings for Newfoundland (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#98 of 510
by report volume (all breeds)
1,299
FDA CVM reports on file
7.0%
death-coded share of reports
#86 of 275
by death-coded share (≥50 reports)

How the 1,299 reports break down

By recorded gender -- every report on file for Newfoundland, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 125 93.75 62.5 31.25 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Newfoundland drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Newfoundland ranks #98 of 510 by total reports (1,299) and #86 of 275 by death-coded share (7.0%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#98
This breed, reports of 510
#86
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Newfoundland has 1,299 reports now versus 1,284 in that prior snapshot: 15 more (1.2%).

Report change
+15
Death-coded reports
+0
Death-coded share
−0.1 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Newfoundland changes

Total Reports

1,299

High report volume

Deaths Reported

91

of 1,299 reports

Death-coded share of reports

7.0%

Above-median death-coded share

Avg Age at Report

4.9 yr

49.0 kg avg weight

Breed Safety Scorecard

F (30/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate F
7.0%

Share of reports coded as a fatality

Euthanasia rate F
3.5%

Share of reports resulting in euthanasia

Full recovery rate F
25.9%

Share of reports coded "Recovered/Normal"

5-year trend F
+18%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Newfoundland death-coded reports 7.0%
Cross-breed median

7.0% of 1,299 newfoundland reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Newfoundland's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

7% 69th percentile Higher share than 69% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Newfoundland 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 49.0 kg (108.0 lbs)

Top Reported Reactions

Vomiting 218
Diarrhoea 122
Lack of efficacy (endoparasite) - hookworm 86
Lack of efficacy - NOS 86
Lethargy (see also Central nervous system depression in 'Neurological') 80
Emesis 68
Anorexia 62
Death by euthanasia 53
INEFFECTIVE, HEARTWORM LARVAE 50
Digestive tract disorder NOS 45
Other abnormal test result NOS 41
Panting 39
Not eating 39
Lack of efficacy (endoparasite) - heartworm 39
Lack of efficacy (endoparasite) - roundworm NOS 37

Most Referenced Drugs

Ivermectin + Pyrantel As Pamoate Salt 176
Milbemycin Oxime + Spinosad 157
Pyrantel Pamoate;Sarolaner 109
Afoxolaner 108
Carprofen 90
Milbemycin Oxime + Praziquantel 83
Bedinvetmab 78
Oclacitinib Maleate 77
Fluralaner Chew Tablets 65
Spinosad 49
Moxidectin 48
Fluralaner 13.64% 12-Week Chew 46
Grapiprant 37
Gabapentin 36
Selamectin 34

Outcome Breakdown

Ongoing
375 (31.1%)
Outcome Unknown
365 (30.2%)
Recovered/Normal
337 (27.9%)
Died
47 (3.9%)
Euthanized
45 (3.7%)
Recovered with Sequela
38 (3.1%)

Gender Distribution

Male 677 (52.1%)
Female 592 (45.6%)
Unknown 21 (1.6%)
Mixed 9 (0.7%)

Reports by Year

Year Reports Trend
2010 43
2011 73
2012 72
2013 50
2014 93
2015 83
2016 109
2017 104
2018 79
2019 72
2020 80
2021 65
2022 75
2023 88
2024 125
2025 77
2026 11

Newfoundland: high death-coded share in the FDA CVM extract

Signature read: 1,299 reports place Newfoundland in the upper third of breed filing volume (#98 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Newfoundland sits at #98 of 510 by report volume among all breeds and #82 of 298 among dog breeds, with 1,299 reports and 91 (7.0%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #86 of 275. Mean age at report: 4.9 years, average weight 49.0 kg (108.0 lbs).

Top reported signs: Vomiting (218), Diarrhoea (122), Lack of efficacy (endoparasite) - hookworm (86). Most-referenced drug: Ivermectin + Pyrantel As Pamoate Salt (176 reports), followed by Milbemycin Oxime + Spinosad (157) and Pyrantel Pamoate;Sarolaner (109).

Outcome coding on 1,207 status-recorded reports is dominated by Ongoing (31.1%). Annual submissions ranged 11-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

High-volume peer sets for Newfoundland drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (7.0% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (49.0 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Newfoundland?
There are 1,299 adverse event reports involving Newfoundland in the FDA database, of which 91 were death-coded (7.0% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Newfoundland ranks #98 of 510 by report volume among all breeds PlainBreed indexes (#82 of 298 among dog breeds).
Where does Newfoundland sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Newfoundland is #98 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #82 of 298. Among breeds with at least 50 reports, its death-coded share ranks #86 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Newfoundland?
The most commonly reported adverse reactions for Newfoundland are Vomiting (218 reports), Diarrhoea (122 reports), Lack of efficacy (endoparasite) - hookworm (86 reports), Lack of efficacy - NOS (86 reports), Lethargy (see also Central nervous system depression in 'Neurological') (80 reports).
What drugs are most frequently associated with Newfoundland adverse events?
The drugs most frequently referenced in Newfoundland adverse event reports are Ivermectin + Pyrantel As Pamoate Salt (176 reports), Milbemycin Oxime + Spinosad (157 reports), Pyrantel Pamoate;Sarolaner (109 reports), Afoxolaner (108 reports), Carprofen (90 reports).
What is the average age of Newfoundland in adverse event reports?
The average age of Newfoundland at the time of adverse event reports is 4.9 years, with an average weight of 49.0 kg (108.0 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Newfoundland (Dog), extract as of July 2026 extract. 1,299 reports · 91 death-coded (7.0% of reports, not a mortality rate) · #98 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →